[EXPERIENCES WITH RIFAMYCIN SV: PRELIMINARY REPORT].
D000818:Animals; D001658:Biliary Fistula; D001996:Bronchopneumonia; D002764:Cholecystitis; D002769:Cholelithiasis; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D004754:Enterobacter; D004926:Escherichia coli; D004927:Escherichia coli Infections; D005667:Furunculosis; D042882:Gallstones; D006801:Humans; D007709:Klebsiella; D008100:Liver Abscess; D008103:Liver Cirrhosis; D010033:Otitis Media; D010600:Pharmacology; D011006:Pneumatosis Cystoides Intestinalis; D011511:Proteus; D011512:Proteus Infections; D012294:Rifamycins; D013203:Staphylococcal Infections; D013210:Staphylococcus
D012294:Rifamycins; C023808:rifamycin SV
AEROBACTER; BILIARY FISTULA; BRONCHOPNEUMONIA; CHOLECYSTITIS; CHOLELITHIASIS; COMMON BILE DUCT CALCULI; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FURUNCULOSIS; KLEBSIELLA; LIVER ABSCESS; LIVER CIRRHOSIS; OTITIS MEDIA; PHARMACOLOGY; PNEUMATOSIS CYSTOIDES INTESTINALIS; PROTEUS; PROTEUS INFECTIONS; RIFOMYCIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS
EXPERIENCIAS CON LA RIFAMICINA SV: INFORME PRELIMINAR.